APA (7th ed.) Citation

Yarur, A. J., Dervieux, T., Ungaro, R., Spencer, E. A., Bruss, A., Nunez, L., . . . Dubinsky, M. C. (2025). Ustekinumab Drug Clearance Is Better Associated with Disease Control than Serum Trough Concentrations in a Prospective Cohort of Inflammatory Bowel Disease †. Pharmaceutics, 17(2), 187. https://doi.org/10.3390/pharmaceutics17020187

Chicago Style (17th ed.) Citation

Yarur, Andres J., et al. "Ustekinumab Drug Clearance Is Better Associated with Disease Control than Serum Trough Concentrations in a Prospective Cohort of Inflammatory Bowel Disease †." Pharmaceutics 17, no. 2 (2025): 187. https://doi.org/10.3390/pharmaceutics17020187.

MLA (9th ed.) Citation

Yarur, Andres J., et al. "Ustekinumab Drug Clearance Is Better Associated with Disease Control than Serum Trough Concentrations in a Prospective Cohort of Inflammatory Bowel Disease †." Pharmaceutics, vol. 17, no. 2, 2025, p. 187, https://doi.org/10.3390/pharmaceutics17020187.